1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Z; Shi, T; Tian, L; Yang, Y | 1 |
1 other study(ies) available for 1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea and Adenocarcinoma
| Article | Year |
|---|---|
Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.
Topics: Adenocarcinoma; Carcinogenesis; Cell Death; Chromosomal Proteins, Non-Histone; Cyclic N-Oxides; Humans; Lung Neoplasms; Prognosis | 2023 |